Literature DB >> 3208627

Relevance of DNA ploidy as a measure of genetic deviation: a comparison of flow cytometry and cytogenetics in 25 cases of human breast cancer.

Y Remvikos1, M Gerbault-Seurreau, P Vielh, B Zafrani, H Magdelénat, B Dutrillaux.   

Abstract

Twenty-five human breast cancers, surgically resected, were studied by cytogenetic analysis and DNA flow cytometry (FCM). The establishment of karyotypes showed that multiple cell populations probably were derived from a single ancestor clone, because common marker chromosomes always could be demonstrated. Differences of up to 30% were observed when the estimates of DNA content by the two methods were compared. A general tendency toward the acquisition of large marker chromosomes should be at the origin of this discordance, as the proportion of markers for each case correlated significantly with the magnitude of the difference. Parallel use of the two methods revealed the existence of tumors with DNA diploid FCM profiles and highly abnormal hypodiploid karyotypes (35-40 chromosomes), which may explain the limited value of DNA ploidy as an independent prognostic factor in breast cancer.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3208627     DOI: 10.1002/cyto.990090616

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  8 in total

1.  Description of a new human breast cancer cell line, IIB-BR-G, established from a primary undifferentiated tumor.

Authors:  L Bover; M Barrio; I Slavutsky; A I Bravo; C Quintans; A Bagnăti; B Lema; J Schiaffi; R Yomha; J Mordoh
Journal:  Breast Cancer Res Treat       Date:  1991-09       Impact factor: 4.872

2.  Breast cancer genetic evolution: I. Data from cytogenetics and DNA content.

Authors:  B Dutrillaux; M Gerbault-Seureau; Y Remvikos; B Zafrani; M Prieur
Journal:  Breast Cancer Res Treat       Date:  1991-11       Impact factor: 4.872

3.  Characterization of four in vitro established canine mammary carcinoma and one atypical benign mixed tumor cell lines.

Authors:  E Hellmén
Journal:  In Vitro Cell Dev Biol       Date:  1992-05

4.  Prognostic value of epidermal growth factor receptor in node-positive breast cancer.

Authors:  M Grimaux; S Romain; Y Remvikos; P M Martin; H Magdelénat
Journal:  Breast Cancer Res Treat       Date:  1989-10       Impact factor: 4.872

5.  Proliferative activity of breast cancers increases in the course of genetic evolution as defined by cytogenetic analysis.

Authors:  Y Remvikos; M Gerbault-Seureau; H Magdelénat; M Prieur; B Dutrillaux
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

6.  Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene.

Authors:  M M Tanner; R A Karhu; N N Nupponen; A Borg; B Baldetorp; T Pejovic; M Fernö; D Killander; J J Isola
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

7.  Complex karyotypes in flow cytometrically DNA-diploid squamous cell carcinomas of the head and neck.

Authors:  J Akervall; Y Jin; B Baldetorp; F Mertens; J Wennerberg
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

8.  DNA flow cytometry of breast cancer fine needle aspirates.

Authors:  Y Remvikos
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.